Provider Resources for COVID-19 and Beyfortus

Scroll for links to helpful resources

*Vaccine Update and Go-Live Plans for Cincinnati Children’s | View Here

  • Pfizer COVID Vaccine 2023-2024 Formula

  • Nirsevimab (Beyfortus) RSV Prevention

Covid-19 resources

Vaccine Information

  • Interim 2023-2024 COVID-19 Immunization Schedule for Persons Age 6+ Months

  • CDC Recommendations for mRNA COVID-19 Vaccines (2023-2024 Formula)

    • For patients NOT moderately or severely immunocompromised | View Graphic

    • For moderately or severely immunocompromised patients | View Graphic

  • 6 mos — 11 Years Pfizer Fact Sheet (2023-2024 Formula)

  • 12+ Years Comirnaty Dosing Schedule (2023-2024 Formula)

  • The CDC recently outlined circumstances in which COVID-19 vaccination brands are interchangeable for children. View details HERE.

Treatment

  • Infectious Disease (ID) Dept. has updated the COVID-19 treatment algorithm (May 2023) to outline potential treatment options. Most patients will not require therapy, but ID is available for questions through Priority Link if needed.

Information for Practices

  • On Jan. 10, the AAP shared an announcement by Moderna making pediatric COVID-19 vaccine 100% returnable. The new policy applies to 0.25 mL doses purchased on Jan. 9 (or later) and will remain in effect for the rest of the season. 

  • DEA Telehealth Updates

Beyfortus Resources